Kobayashi Pharmaceutical Co (TSE:4967) EV-to-Revenue : 1.90 (As of May. 11, 2024)

Kobayashi Pharmaceutical Co EV-to-Revenue Chart

Kobayashi Pharmaceutical Co Annual Data
	Trend	Mar14	Mar15	Mar16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-Revenue		Get a 7-Day Free Trial					4.01	5.93	3.83	3.50	2.46

Kobayashi Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															3.50	3.09	2.95	2.42	2.46

Competitive Comparison of Kobayashi Pharmaceutical Co's EV-to-Revenue

For the Household & Personal Products subindustry, Kobayashi Pharmaceutical Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kobayashi Pharmaceutical Co's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kobayashi Pharmaceutical Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Kobayashi Pharmaceutical Co's EV-to-Revenue falls into.

Kobayashi Pharmaceutical Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Kobayashi Pharmaceutical Co's EV-to-Revenue for today is calculated as:

Kobayashi Pharmaceutical Co's current Enterprise Value is 円329,420 Mil.
Kobayashi Pharmaceutical Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円173,455 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co  (TSE:4967) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Kobayashi Pharmaceutical Co's PS Ratiofor today is calculated as:

Kobayashi Pharmaceutical Co's share price for today is 円5492.00.
Kobayashi Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,289.12.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobayashi Pharmaceutical Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Kobayashi Pharmaceutical Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Kobayashi Pharmaceutical Co (TSE:4967) Business Description